Deutsche Bank Ag\ Avidity Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 163,246 shares of RNA stock, worth $7.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163,246

Previous 146,570 11.38%

Holding current value

$7.13 Million

Previous $5.99 Million 25.22%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$37.21 - $48.14 $620,513 - $802,782	16,676 Added 11.38%	163,246 $7.5 Million
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $268,691 - $482,887	11,821 Added 8.77%	146,570 $5.99 Million
Q1 2024 May 15, 2024	SELL	$9.16 - $25.52 $5.75 Million - $16 Million	-628,100 Reduced 82.34%	134,749 $3.44 Million
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $3.06 Million - $5.89 Million	628,299 Added 466.96%	762,849 $6.9 Million
Q3 2023 Nov 09, 2023	BUY	$6.3 - $11.35 $29,912 - $53,889	4,748 Added 3.66%	134,550 $858,000
Q2 2023 Aug 14, 2023	SELL	$10.62 - $17.34 $373,855 - $610,420	-35,203 Reduced 21.33%	129,802 $1.44 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $200,731 - $335,425	13,077 Added 8.61%	165,005 $2.53 Million
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $107,420 - $241,963	10,678 Added 7.56%	151,928 $3.37 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $251,874 - $381,721	16,292 Added 13.04%	141,250 $2.31 Million
Q2 2022 Aug 11, 2022	BUY	$11.18 - $20.5 $27,301 - $50,061	2,442 Added 1.99%	124,958 $1.82 Million
Q1 2022 May 13, 2022	SELL	$14.2 - $23.78 $34,392 - $57,595	-2,422 Reduced 1.94%	122,516 $2.26 Million
Q4 2021 Feb 11, 2022	SELL	$20.4 - $28.66 $4.5 Million - $6.32 Million	-220,372 Reduced 63.82%	124,938 $2.97 Million
Q3 2021 Nov 04, 2021	BUY	$18.16 - $25.21 $66,937 - $92,924	3,686 Added 1.08%	345,310 $8.51 Million
Q2 2021 Aug 11, 2021	SELL	$19.62 - $29.26 $2,589 - $3,862	-132 Reduced 0.04%	341,624 $8.44 Million
Q1 2021 May 13, 2021	BUY	$20.28 - $28.15 $4.65 Million - $6.46 Million	229,472 Added 204.37%	341,756 $7.45 Million
Q4 2020 Feb 16, 2021	BUY	$24.73 - $35.12 $82,796 - $117,581	3,348 Added 3.07%	112,284 $2.87 Million
Q3 2020 Nov 12, 2020	BUY	$23.35 - $35.94 $208,655 - $321,159	8,936 Added 8.94%	108,936 $3.07 Million
Q2 2020 Aug 13, 2020	BUY	$26.62 - $31.5 $2.66 Million - $3.15 Million	100,000 New	100,000 $2.83 Million

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account